Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT06241300 · ClinicalTrials.gov registry record · NA
Executive Function and Parenting in Childhood
A NA study of Disruptive Behavior and Executive Function, sponsored by University of Illinois at Chicago.
- Recruiting
- Registry status
- NA
- Development phase
- 180
- Enrollment target
- 1
- Study location
NCT06241300: Recruiting NA study of Disruptive Behavior and Executive Function, sponsored by University of Illinois at Chicago.
NCT06241300 is a NA study of Disruptive Behavior and Executive Function that is actively recruiting participants, run by University of Illinois at Chicago. The registered enrollment target is 180 participants, above the 88-participant average among 7 other Disruptive Behavior trials with a reported enrollment target (105% higher). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT06241300, a NA study of Disruptive Behavior and Executive Function, is actively recruiting participants, sponsored by University of Illinois at Chicago.
- RECRUITING
- Registry status
- NA
- Development phase
- 180 participants
- Enrollment target
- 1
- Study location
Study Summary
Deficits in executive functioning (EF) disproportionately impact children living in poverty and increase risk for psychopathology, particularly disruptive behavior disorders. This randomized clinical trial seeks to determine whether childhood EF, assessed across neural and behavioral units of analysis, is an experimental therapeutic target that can be directly modified through caregiver participation in the Chicago Parent Program (CPP), if increases in EF predict reduced disruptive behavior trajectories in low-income children over a short-term follow-up period, and identify which CPP-driven parenting skill improvements are the most influential in modifying EF. This work will contribute new knowledge as to whether a cost-efficient parenting intervention, developed for and with low-income families raising young children in poverty, can modify EF, a neural behavioral mechanism implicated in risk for childhood disruptive behavior problems.
Primary Outcome
Parents will complete the BRIEF-P to assess their child's executive functioning, and the Global Executive Composite score will be used in the analysis.
Conditions Studied
Interventions
- BEHAVIORAL Chicago Parent Program
Study Locations (1)
Illinois
- University of Illinois-Chicago - Chicago
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 180 participants |
| Start Date | 2023-11-20 |
| Est. Completion | 2028-03-31 |
| Phase | NA |
What NCT06241300 shows while recruiting
NCT06241300 is an interventional study that assigns participants to a tested intervention. The registered 180 participants enrollment target is mid-sized for trials with a published cap, above the 88-participant average among 7 other Disruptive Behavior trials with a reported enrollment target (105% higher).
The record links to 3 conditions, with Disruptive Behavior appearing as the primary indexed condition, and to 1 intervention - of which Chicago Parent Program is the first listed.
NCT06241300 reports a single indexed study location in Illinois.
Frequently Asked Questions
What is clinical trial NCT06241300 about?
NCT06241300 is a clinical study titled "Executive Function and Parenting in Childhood". Deficits in executive functioning (EF) disproportionately impact children living in poverty and increase risk for psychopathology, particularly disruptive behavior disorders. This randomized clinical trial seeks to determine whether childhood EF, assessed across neural and behavioral units of analys...
What is the current status of trial NCT06241300?
This trial is currently recruiting. It is a NA study. The enrollment target is 180 participants. The study started on 2023-11-20. Estimated completion is 2028-03-31.
What conditions does trial NCT06241300 study?
This clinical trial studies the following conditions: Disruptive Behavior, Executive Function, Disruptive Behavior Disorder, Childhood Onset.
What interventions are being tested in trial NCT06241300?
The interventions under investigation include: Chicago Parent Program (BEHAVIORAL).
Who is sponsoring clinical trial NCT06241300?
This trial is sponsored by University of Illinois at Chicago, which has 430 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT06241300 being conducted?
This trial has 1 study location across Illinois. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Disruptive Behavior
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
Feasibility and Acceptability of Internet-based Parent-child Interaction Therapy (I-PCIT) in Pediatric Cancer
RECRUITING · NA
-
Randomized Controlled Trial of a Behavioral Training App
RECRUITING · NA
-
Tele-PCIT for Healthy Relationships in Families At-Risk
RECRUITING · NA
-
Behavior Therapy for Irritability in Autism
ACTIVE NOT RECRUITING · NA
-
Telemedicine-based, Multidisciplinary-team, Intervention to Reduce Unnecessary Hospitalizations
COMPLETED · NA
-
Mindful Parenting and Parent Training Program Study
COMPLETED · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT01558804 · 180 participants
GRoup A StrePtococcus
- NCT02932176 · 180 participants
Machine Learning for Handheld Vascular Studies
- NCT03384563 · 180 participants · Phase 4
Effect of Dexmedetomidine on the Minimum Alveolar Concentration of Sevoflurane
- NCT03423628 · 180 participants · Phase 1
A Study to Assess the Safety and Tolerability of AZD1390 Given With Radiation Therapy in Patients With Brain Cancer
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI